Regencell Bioscience Holdings Ltd [NASDAQ: RGC] loss -8.05% on the last trading session, reaching $14.05 price per share at the time.
Regencell Bioscience Holdings Ltd represents 494.49 million in outstanding shares, while the company has a total market value of $6.95 billion with the latest information. RGC stock price has been found in the range of $14.0 to $15.12.
If compared to the average trading volume of 1.34M shares, RGC reached a trading volume of 277823 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Regencell Bioscience Holdings Ltd [RGC]:
The Price to Book ratio for the last quarter was 27.23, with the Price to Cash per share for the same quarter was set at 0.02.
Trading performance analysis for RGC stock
Regencell Bioscience Holdings Ltd [RGC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.77. With this latest performance, RGC shares gained by 6.44% in over the last four-week period, additionally plugging by 11506.52% over the last 6 months – not to mention a rise of 10707.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RGC stock in for the last two-week period is set at 50.06, with the RSI for the last a single of trading hit 1.19, and the three-weeks RSI is set at 2.16 for Regencell Bioscience Holdings Ltd [RGC]. The present Moving Average for the last 50 days of trading for this stock 15.52, while it was recorded at 13.88 for the last single week of trading, and 6.96 for the last 200 days.
Regencell Bioscience Holdings Ltd (RGC) Capital Structure & Debt Analysis
According to recent financial data for Regencell Bioscience Holdings Ltd. ( RGC), the Return on Equity (ROE) stands at -48.45%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -45.55%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Regencell Bioscience Holdings Ltd’s Return on Invested Capital (ROIC) is -60.89%, showcasing its effectiveness in deploying capital for earnings.
Regencell Bioscience Holdings Ltd (RGC) Efficiency & Liquidity Metrics
Based on Regencell Bioscience Holdings Ltd’s (RGC) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Regencell Bioscience Holdings Ltd (RGC) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Regencell Bioscience Holdings Ltd. (RGC) effectively leverages its workforce, generating an average of -$340833.33 per employee. The company’s liquidity position is robust, with a Current Ratio of 41.92% and a Quick Ratio of 41.92%, indicating strong ability to cover short-term liabilities.
An analysis of Institutional ownership at Regencell Bioscience Holdings Ltd [RGC]
There are presently around $0.14%, or 3.64%% of RGC stock, in the hands of institutional investors. The top three institutional holders of RGC stocks are: UBS GROUP AG with ownership of 312.0 shares, which is approximately 0.0024%. BLACKROCK INC., holding 238.0 shares of the stock with an approximate value of $$800.0 in RGC stocks shares; and BLACKROCK INC., currently with $$44.0 in RGC stock with ownership which is approximately 0.0001%.
